Bionano Genomics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Bionano Genomics, Inc. reported Cash And Cash Equivalents At Carrying Value of $2.99 million for the year ending 2025.

  • Bionano Genomics, Inc. showed a decrease of -67.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Bionano Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Bionano Genomics, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 192.6%.
  • Historical annual values: Fiscal year 2025: $2.99 million | Fiscal year 2024: $9.17 million | Fiscal year 2023: $17.95 million | Fiscal year 2022: $5.09 million | Fiscal year 2021: $24.57 million | Fiscal year 2020: $38.45 million | Fiscal year 2019: $17.31 million | Fiscal year 2018: $16.52 million | Fiscal year 2017: $1.02 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: